MetaCap

Bio-Rad Laboratories (BIO) vs Waters (WAT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Bio-Rad Laboratories (BIO) has outperformed Waters (WAT) over the past year, gaining 13.3% versus a gain of 11.8%. Over five years, WAT leads with a +30.1% price change compared with -52.2% for BIO. Waters is the larger company by market cap ($86.56 billion vs $9.65 billion), about 9.0 times the size.

On valuation, Waters trades at a lower forward P/E (26.6x vs 36.2x for Bio-Rad Laboratories). Bio-Rad Laboratories converts more of its revenue into profit, with a net margin of 29.4% versus 20.3%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

BIO+13.32%WAT+11.79%
+26%-2%-31%
Nov 21, 20251 yearNov 20, 2026
BIO-53.79%WAT+25.95%
+38%-20%-77%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

BIO versus WAT key metrics
MetricBIOWAT
Share price$358.90$440.45
Market cap$9.65B$86.56B
1-day change-2.34%-3.51%
YTD return+18.45%+15.96%
1-year return+13.32%+11.79%
5-year return-52.16%+30.15%
P/E ratio (TTM)9.54184.29
Forward P/E36.2326.65
EPS (TTM)$37.64$2.39
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$2.58B$3.17B
Revenue growth (YoY)+0.65%+6.99%
Net income (latest FY)$759.90M$642.63M
Gross margin51.87%59.28%
Operating margin1.83%25.36%
Net margin29.42%20.30%
52-week high$396.23$483.33
52-week low$236.73$282.77
Distance from 52-week high-9.42%-8.87%
Analyst consensusholdbuy
Avg. price target upside-0.62%+14.27%
Average volume257.70K826.62K
Shares outstanding21.83M98.29M
Employees7,45015,000
SectorIndustrialsIndustrials
IndustryBiotechnology: Laboratory Analytical InstrumentsBiotechnology: Laboratory Analytical Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Waters is about 9.0 times larger than Bio-Rad Laboratories by market value ($86.56B vs $9.65B).
  • Waters trades at a higher earnings multiple (184.3x vs 9.5x trailing P/E).
  • Bio-Rad Laboratories is more profitable, keeping 29.4 cents of every revenue dollar as net income versus 20.3 cents for Waters.
  • Waters grew revenue faster in its latest fiscal year (+6.99% vs +0.65%).

About Bio-Rad Laboratories

BIO stock →

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally.

Industrials · Biotechnology: Laboratory Analytical Instruments · 7,450 employees

About Waters

WAT stock →

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA.

Industrials · Biotechnology: Laboratory Analytical Instruments · 15,000 employees

BIO vs WAT FAQ

Which is bigger, Bio-Rad Laboratories or Waters?

Waters (WAT) is larger, with a market capitalization of $86.56B compared with $9.65B for Bio-Rad Laboratories (BIO).

Which stock has performed better over the past year, BIO or WAT?

BIO returned +13.32% over the past 12 months, compared with +11.79% for WAT (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, BIO or WAT?

BIO has the lower trailing P/E at 9.5, versus 184.3 for WAT. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Are Bio-Rad Laboratories and Waters in the same industry?

Yes. Both are classified in the Biotechnology: Laboratory Analytical Instruments industry within the Industrials sector.

More comparisons